公司資料
Inozyme 股價、新聞與催化劑
- 股票代碼:
- INZY
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for INZY.
公司概覽
業務概覽
Inozyme Pharma is a rare-disease company focused on tissue calcification and enzyme replacement biology. Its story centers on highly specialized pediatric and orphan indications.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Inozyme sits in specialty biotechnology.
商業模式特徵
The business depends on clinical data, orphan-disease progress, and the ability to build value in a narrow rare-disease market.
生技產業定位
Inozyme is a rare-disease catalyst name whose stock reacts to proof-of-concept and regulatory steps.
未來催化劑
- Inozyme’s catalyst is INZ-701 in ENPP1 deficiency, plus any next-stage update that supports the mineralization-disease thesis. This remains a focused rare-disease story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。